WO1992001439A1 - Concentre pour cremes, lotions et autres preparations similaires pour la peau - Google Patents
Concentre pour cremes, lotions et autres preparations similaires pour la peau Download PDFInfo
- Publication number
- WO1992001439A1 WO1992001439A1 PCT/SE1991/000482 SE9100482W WO9201439A1 WO 1992001439 A1 WO1992001439 A1 WO 1992001439A1 SE 9100482 W SE9100482 W SE 9100482W WO 9201439 A1 WO9201439 A1 WO 9201439A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- mixture
- concentrate
- lotion
- vitamin
- Prior art date
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 19
- 239000012141 concentrate Substances 0.000 title claims abstract description 13
- 239000006071 cream Substances 0.000 title abstract description 6
- 238000002360 preparation method Methods 0.000 title description 19
- 230000000694 effects Effects 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 12
- 235000019155 vitamin A Nutrition 0.000 claims description 8
- 239000011719 vitamin A Substances 0.000 claims description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 229940108325 retinyl palmitate Drugs 0.000 claims 1
- 235000019172 retinyl palmitate Nutrition 0.000 claims 1
- 239000011769 retinyl palmitate Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 abstract description 5
- 230000035876 healing Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 8
- 230000037303 wrinkles Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000003679 aging effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241001307210 Pene Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- FCASKLHVRFDIJB-UHFFFAOYSA-N Riboflavine Natural products Cc1cc2N=C3C(NC(=O)NC3=O)N(CC(O)C(O)C(O)CO)c2cc1C FCASKLHVRFDIJB-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127090 anticoagulant agent Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000280 vitalizing effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the purpose of the subject invention is to provide a concentrate of active substances which, in a particular combination, may be added to all commercially available skin lotions, creams, foot-care creams, and similar products.
- the addition of the concentrate in accordance with the subject invention increases the efficiency rate of such products to a maximum degree. Own their own, such products cannot penetrate all the way into the stratum corneum of the skin to rehabilitate it without the aid of e.g. vitamin A.
- the invention concerns a mixture which may be added to "ordinary" lotions and the like in the form of e.g. a tablet, a dragee or as a liquid con ⁇ tained in a bottle or an ampoule, preferably as a one-dose pipette, to give a product having a very good effect.
- An additive of this kind thus is to contain the ingredients providing the effects that one wishes to obtain, as will be described in the following.
- Vitamin A counteracts the effects of the free radi- cals and accelerates the rate of cell division in the epidermis. It makes the stratum corneum thinner, thus resulting in an increase of the blood supply in this layer. It also regenerates the collagen in the connective tissue of the skin, resulting in slow disappearance of the brown discoloration of the skin which is a sign of old age.
- vitamin A to some extent has a beneficial effect on eczema.
- Vitamin E which is an anticoagulant agent, pene ⁇ trates into the skin and prevents the fat in the skin layer cells from oxidizing. In addition, vitamin E prevents vitamin A from combining with oxygen and dis ⁇ integrate.
- Silicic acid should be included since it contributes to the reinforcement and regeneration of the cells of the connective tissue of the skin. In addition, it contributes to the reparation of cells damaged by the UV rays during sunbathing.
- Zinc is a valuable additive, having stimulating effects on the generation of cells.
- Prosolat is a filter with protective effects against UV radiation, particularly the especially pernicious UVB rays.
- Vitamin C has an adstringent effect, i.e. it has a rejuvenating effect on the skin cells and kills harmful bacteria.
- Pantothenic acid increases the energy metabolism of the cells, and protects against and reduces damages caused by sun rays and X-rays.
- vitamin B riboflavine
- these agents and substances may be combined into a concentrate which, in the form of a liquid dose, may be added to a lotion, and these doses may be distri ⁇ minded in bottles, in one-dose pipettes or in the form of pills. This has proved to be possible, provided the products are mixed in accordance with the specification of claim 1.
- This preparation which thus is obtained when the concentrate in accordance with the invention is mixed in the specified amounts with 50 ml of a lotion, should be used over a prolonged period in order to be efficient, and by prolonged period in this case should be understood at least 12 months.
- the rate of ageing being, of course, highly dependent on the genetic heredity. Skin ageing may manifest itself in deep lines and round ridges. The skin becomes dry and scaly, exhib ⁇ iting localized discolorations, known as old age spots.
- the supply of blood to the skin becomes irregular and cracks appear easily, in addition to which the skin becomes very thin and as a result parched and wrinkled. Deep veins may become visible, which is a consequence of the disappearance of connective tissue.
- the skin may whiten as a result of faulty capillaries and it may become flabby as a result of disturbances in the ability of the skin to retain water in the deeper layers.
- the ageing of the skin may be affected and that even already existing damage may be repaired, or, in other words, that it is possible to rejuvenate the skin, by using a lotion which is enriched with the concentrate having the compo- sition defined in accordance with the invention.
- effects may be noticeable already after a treatment period of two months, the treatment should be continued up to 18 months to achieve maximum effects.
- the product in accordance with the invention hasa particularly good effect since one has found that the discrete components not only have the above-referred to separate effects but that in addition thereto, besides being compatible, the components quite unexpectedly mutually reinforce the above-stated effects specific to each individual compo ⁇ nent, at least in several cases.
- the tests were carried out for a period of 14 months and the tests involved 10 women, aged 30-70 years and thus exhibiting different degrees of wrinkle generation. All ten women were given a preparation in the form of a cheap, commercially available lotion which was enriched with vitamin A and vitamin E. The preparation was applied on the entire body once a day. The skin become rosy and small surface wrinkles disappeared after a treatment period of six months. However, the deep wrinkles remained. The younger women withdrew from the test at this point since they did not have any deep wrinkles, whereas the older women, i.e. aged 50-70, continued the experiment.
- Preparation 1 was enriched with vitamins A and E whereas Preparation 2 was enriched with the concentrate in accordance with the subject invention.
- the tests were carried out in the following manner. The women applied Preparation 1 on one half of the body and Preparation 2 on the other half. Preparation 1 continued to smoothen existing wrinkles at a slow pace whereas Preparation 2 increased the rate of this activity and in addition thereto was found to have a deeper effect.
- the product in accordance with the invention is primarily intended to be used on normal skins. Persons with sensitive skin may find that the skin becomes somewhat rosy and slightly irritated at the beginning of the treatment. However, these effects may be eliminated by diluting the prepared lotion with a further amount of lotion and by using lotion thus diluted for about two months. Adoption of a trial-and-error method is recom- mended to find the strength suitable to the individual's skin.
- the product may be supplemented with perfumes, buffered, diluted with water, and in this connection it should be pointed out that these additives serve to have an effect on certain qualities of the product without changing its effects on the skin, for instance qualities that make the product more easy to apply or increase its shelf-life.
- the concentrate may be added to creams as well as to lotions.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Concentré renfermant plusieurs adjuvants ayant un effet régénérant et cicatrisant sur la peau. Le concentré est destiné à être ajouté à des lotions, des crèmes et autres et il est destiné, en premier lieu, à être distribué dans des pipettes unidoses.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9002447A SE468541B (sv) | 1990-07-17 | 1990-07-17 | Koncentrerad blandning innehaallande vitaminer foer tillsats till hudvaardsmedel |
| SE9002447-2 | 1990-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1992001439A1 true WO1992001439A1 (fr) | 1992-02-06 |
Family
ID=20380012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/SE1991/000482 WO1992001439A1 (fr) | 1990-07-17 | 1991-07-08 | Concentre pour cremes, lotions et autres preparations similaires pour la peau |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU8233591A (fr) |
| SE (1) | SE468541B (fr) |
| WO (1) | WO1992001439A1 (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2717079A1 (fr) * | 1994-03-11 | 1995-09-15 | Oreal | Composition contenant un oxyde de métal non photocatalytique et du tocophérol, son utilisation dans le domaine cosmétique et/ou dermatologique et procédés la mettant en Óoeuvre. |
| WO1995027491A1 (fr) * | 1994-04-11 | 1995-10-19 | Jean Berque | Compositions d'entre autres la riboflavine pour la protection locale des muqueuses genitales et rectales |
| WO2000032155A3 (fr) * | 1998-12-04 | 2000-11-23 | Johnson & Johnson Consumer | Compositions pour soins de la peau renfermant des sels de zinc et des retinoides |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2309338A1 (de) * | 1972-11-06 | 1974-05-22 | Colette Jacqueline Pierret | Verfahren zur schoenheitspflege und produkte zur ermoeglichung des einsatzes desselben |
| EP0330583A2 (fr) * | 1988-02-26 | 1989-08-30 | L'oreal | Méthode pour améliorer l'aspect esthétique de la peau à l'aide de mélanges polyvitaminiques et compositions cosmétiques pour sa mise en oeuvre |
| EP0343444A2 (fr) * | 1988-05-25 | 1989-11-29 | Bayer Ag | Composition cosmétique à base de rétinyl palmitate |
| EP0343694A2 (fr) * | 1984-03-07 | 1989-11-29 | Roshdy Dr. Ismail | Agent pour le traitement et la protection de la peau |
-
1990
- 1990-07-17 SE SE9002447A patent/SE468541B/sv not_active IP Right Cessation
-
1991
- 1991-07-08 WO PCT/SE1991/000482 patent/WO1992001439A1/fr unknown
- 1991-07-08 AU AU82335/91A patent/AU8233591A/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2309338A1 (de) * | 1972-11-06 | 1974-05-22 | Colette Jacqueline Pierret | Verfahren zur schoenheitspflege und produkte zur ermoeglichung des einsatzes desselben |
| EP0343694A2 (fr) * | 1984-03-07 | 1989-11-29 | Roshdy Dr. Ismail | Agent pour le traitement et la protection de la peau |
| EP0330583A2 (fr) * | 1988-02-26 | 1989-08-30 | L'oreal | Méthode pour améliorer l'aspect esthétique de la peau à l'aide de mélanges polyvitaminiques et compositions cosmétiques pour sa mise en oeuvre |
| EP0343444A2 (fr) * | 1988-05-25 | 1989-11-29 | Bayer Ag | Composition cosmétique à base de rétinyl palmitate |
Non-Patent Citations (2)
| Title |
|---|
| PATENT ABSTRACTS OF JAPAN, Vol. 11, No. 3, C395; & JP,A,61 183 206, 15-08-1986, LION CORP. * |
| PATENT ABSTRACTS OF JAPAN, Vol. 12, No. 450, C547; & JP,A,63 174 911, 17-07-1988, SHISEIDO CO LTD. * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2717079A1 (fr) * | 1994-03-11 | 1995-09-15 | Oreal | Composition contenant un oxyde de métal non photocatalytique et du tocophérol, son utilisation dans le domaine cosmétique et/ou dermatologique et procédés la mettant en Óoeuvre. |
| US5695771A (en) * | 1994-03-11 | 1997-12-09 | L'oreal | Composition containing a non-photocatalytic metal oxide and tocopherol its use in treating light induced signs of aging |
| EP0676187A3 (fr) * | 1994-03-11 | 1997-12-29 | L'oreal | Composition contenant un oxyde de métal non photocatalytique et du tocophérol, son utilisation dans le domaine cosmétique et/ou dermatologique et procédés la mettant en oeuvre |
| US6103247A (en) * | 1994-03-11 | 2000-08-15 | L'oreal | Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it |
| WO1995027491A1 (fr) * | 1994-04-11 | 1995-10-19 | Jean Berque | Compositions d'entre autres la riboflavine pour la protection locale des muqueuses genitales et rectales |
| WO2000032155A3 (fr) * | 1998-12-04 | 2000-11-23 | Johnson & Johnson Consumer | Compositions pour soins de la peau renfermant des sels de zinc et des retinoides |
Also Published As
| Publication number | Publication date |
|---|---|
| SE9002447L (sv) | 1992-01-18 |
| SE9002447D0 (sv) | 1990-07-17 |
| SE468541B (sv) | 1993-02-08 |
| AU8233591A (en) | 1992-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002309036B2 (en) | Preparation for hair and/or scalp | |
| AU2003303628B2 (en) | Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis | |
| US5505948A (en) | Home skin peel composition for producing healthy and attractive skin | |
| KR100542606B1 (ko) | 피부 및 조직 케어 및/또는 치료 제제 | |
| US8303941B2 (en) | Chelated mineral water | |
| JP2000191498A (ja) | コラ―ゲン産生促進剤および皮膚外用剤 | |
| CN104586695A (zh) | 含仙人掌精华具有深度补水保湿功效的护肤品 | |
| CN110664644A (zh) | 一种含叶酸的护肤组合物、精华及其制备方法 | |
| WO2012058722A1 (fr) | Procédés et compositions pour maintenir et améliorer la santé de la peau | |
| JP2006514957A (ja) | 顔面のしわを治療するスベリヒユの使用 | |
| US6267948B1 (en) | Dermatological formulations and methods | |
| US20100135944A1 (en) | Methods for darkening the skin and/or hair | |
| CN109310724A (zh) | 一种用于皮肤和/或头发护理和/或治疗的组合物 | |
| RU2314093C2 (ru) | Лечебно-косметическое средство | |
| Panfilov | Aesthetic surgery of the facial mosaic | |
| WO1992001439A1 (fr) | Concentre pour cremes, lotions et autres preparations similaires pour la peau | |
| RU2183954C1 (ru) | Косметическое средство для комплексного ухода за кожей и способ его применения | |
| RU2195255C2 (ru) | Косметическое и дерматологическое средство и способ обработки кожи и/или кератиновых материалов | |
| WO2013054760A1 (fr) | Cosmétique | |
| RU2266733C1 (ru) | Липосомальное средство для лечения и ухода за жирным типом волос | |
| JPH0525017A (ja) | 肌改良組成物及び養毛用組成物 | |
| RU2074705C1 (ru) | Средство для укрепления волос | |
| KR100521787B1 (ko) | 피부 또는 머리카락을 개선하기 위한 조성물 | |
| RU2458682C2 (ru) | Крем-гель малавтилин премиум серии "эффектон" | |
| RU2281751C2 (ru) | Липосомальный концентрат для лечения и ухода за жирным типом волос |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MC MG MN MW NL NO PL RO SD SE SU US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |